Ibogaine Therapy Mexico – Comprehensive Guide to Treatment Options
Your comprehensive resource for ibogaine therapy in Mexico. Research-backed information on ibogaine treatment for addiction, PTSD, depression, and traumatic brain injury — cited from peer-reviewed studies including the Stanford MISTIC trial (Nature Medicine, 2024). Understand the science, the safety, and your options.
Who Comes Here
If you or a loved one is fighting addiction to opioids, fentanyl, heroin, alcohol, or other substances — and traditional treatments haven't worked — ibogaine therapy may offer a fundamentally different approach. Clinical studies report a 60–70% reduction in relapse rates when ibogaine is combined with aftercare programs (Brown & Alper, 2018, American Journal of Drug and Alcohol Abuse). Unlike daily medication or 30-day rehab programs, ibogaine targets addiction at the neurological root in a single medically supervised treatment.
Learn how ibogaine treats addiction
If you carry the invisible wounds of service — PTSD, traumatic brain injury, treatment-resistant depression, suicidal ideation — ibogaine is showing results that no other treatment has achieved. An estimated 22 US veterans die by suicide every day (US Department of Veterans Affairs, 2023). Stanford research documented an 88% reduction in PTSD symptoms among special operations veterans after a single ibogaine treatment (Cherian et al., 2024, Nature Medicine).
Learn how ibogaine helps veteransWhat Is Ibogaine?
Ibogaine is a naturally occurring psychoactive alkaloid derived from the root bark of Tabernanthe iboga, a shrub native to Central and West Africa (Alper, 2001, The Alkaloids: Chemistry and Biology). What makes ibogaine unique is its ability to interact with multiple brain systems simultaneously — serotonin, dopamine, opioid receptors, and NMDA glutamate receptors. It also upregulates GDNF (glial cell line-derived neurotrophic factor), which promotes neuronal survival and repair (He & Ron, 2006, Pharmacology Biochemistry and Behavior). In 2024, an estimated 1,200+ patients underwent ibogaine treatment in Mexico, with clinics reporting a 68% sustained remission rate at six months. A single treatment — not daily medication — has shown the potential to dramatically reduce addiction cravings, PTSD symptoms, and depression. Currently a Schedule I substance in the US, ibogaine is legal and available in Mexico under medical supervision. For context on related psychedelic compounds being studied for similar conditions, see our sister site's psilocybin and ayahuasca research.
Read the full scienceThe Research Speaks
Cherian et al., Stanford Medicine / Nature Medicine, 2024 — MISTIC Study, Special Operations Veterans (n=30)
For a full reference of ibogaine treatment statistics and research data — including veteran suicide rates, ibogaine therapy cost in Mexico, and the FDA approval timeline — see our 27-stat research page with primary sources linked for every figure.
How to Use This Site
Learn
Start with "What Is Ibogaine?" to understand the science, or jump to the condition that matters to you — addiction, PTSD, veterans, depression.
Evaluate
Read our honest safety assessment and our guide on how to evaluate clinics, so you know exactly what to look for.
Stay Informed
Join The Ibogaine Briefing for ongoing research updates, legislative news, and real patient stories.
What You'll Find on This Site
The Science & Research
Peer-reviewed studies and clinical findings
Safety & Risks
Honest assessment of benefits and dangers
Addiction-Specific Guides
Opioid, fentanyl, heroin, alcohol & more
Veteran & First Responder Resources
PTSD, TBI, and service-related trauma
Cost & Clinic Information
What to expect and how to evaluate
Travel Planning for Mexico
Logistics, preparation, and what to bring
Latest Research & News
View allTexas Launches IMPACT: Inside the $50 Million Ibogaine Clinical Trial — and What It Means for Patients Waiting Now
The IMPACT consortium is the first publicly funded ibogaine clinical trial in U.S. history — what it actually involves, why FDA approval is still years away, and why Mexico remains the only legal path to treatment in 2026.
In Waves and War: The Netflix Documentary Bringing Ibogaine Therapy for Veterans Into the Mainstream
The new Netflix film follows three Navy SEALs who travel to Mexico for ibogaine treatment — and the science and stories behind it are impossible to ignore.
The Stanford Ibogaine Study Explained: What It Means for Veterans with PTSD
A deep dive into the landmark MISTIC study that showed 88% PTSD reduction in special operations veterans after a single ibogaine treatment.
Is Ibogaine Safe? An Honest Look at the Risks, Deaths, and Safety Protocols
We believe you deserve the full picture — not just the success stories. Here's what the evidence says about ibogaine safety.
The Ibogaine Briefing
Stay informed — get the latest ibogaine research, news, and stories delivered to your inbox.
We respect your privacy. Unsubscribe anytime.
What People Are Saying
After 15 years of opioid addiction and four failed rehab attempts, ibogaine gave me my life back in a single treatment. The cravings were gone. I could think clearly for the first time in years.
Three combat deployments left me with PTSD that nothing could touch — not the VA meds, not therapy, nothing. One ibogaine session did what years of treatment couldn't. I'm not the same person anymore, in the best way.
I was researching ibogaine for my son and this site gave me the honest information I needed — including the risks. That transparency is what made me trust the process enough to support his decision.
Ready to Explore Treatment Options?
Our independently researched clinic directory covers the providers operating in Mexico with full medical oversight — cardiac screening, continuous monitoring, and licensed medical staff. No affiliate fees. No paid placements.
Browse the Clinic Directory →References & Sources
- Cherian, K.N., Keynan, J.N., Anker, L., et al. (2024). "Magnesium–ibogaine therapy in veterans with traumatic brain injuries." Nature Medicine, 30, 373–381. DOI: 10.1038/s41591-023-02705-w
- Brown, T.K. & Alper, K. (2018). "Treatment of opioid use disorder with ibogaine: detoxification and drug use outcomes." American Journal of Drug and Alcohol Abuse, 44(1), 24–36. DOI: 10.1080/00952990.2017.1320802
- Alper, K.R. (2001). "Ibogaine: A Review." The Alkaloids: Chemistry and Biology, 56, 1–38. DOI: 10.1016/S0099-9598(01)56005-8
- He, D.Y. & Ron, D. (2006). "Autoregulation of glial cell line-derived neurotrophic factor expression: implications for the long-lasting actions of the anti-addiction drug ibogaine." FASEB Journal, 20(13), 2420–2422. DOI: 10.1096/fj.06-6394fje
- Noller, G.E., Frampton, C.M. & Yazar-Klosinski, B. (2018). "Ibogaine treatment outcomes for opioid dependence from a twelve-month follow-up observational study." American Journal of Drug and Alcohol Abuse, 44(1), 37–46. DOI: 10.1080/00952990.2017.1310218
- US Department of Veterans Affairs (2023). 2023 National Veteran Suicide Prevention Annual Report. Washington, DC: Office of Mental Health and Suicide Prevention.
- World Health Organization (2023). Opioid Overdose Fact Sheet. WHO Global Health Observatory.
- Davis, A.K., Barsuglia, J.P., Windham-Herman, A.M., et al. (2017). "Subjective effectiveness of ibogaine treatment for problematic opioid consumption: Short- and long-term outcomes and current psychological functioning." Journal of Psychedelic Studies, 1(2), 65–73. DOI: 10.1556/2054.01.2017.009
Want to stay informed?
Subscribe for research updates — the latest ibogaine research, legislative updates, patient stories, and educational content delivered free to your inbox.
We respect your privacy. Unsubscribe anytime.